|
EC 1.1.3.* (oxidoreductase acting on donor CH-OH group, oxygen as acceptor) inhibitor
|
CHEBI_76836 |
|
|
protein synthesis inhibitor
|
CHEBI_48001 |
|
|
neurofibrosarcoma
|
DOID_3512 |
|
|
neurofibroma
|
DOID_962 |
|
|
benign ependymoma
|
DOID_4844 |
|
|
benign glioma
|
DOID_0060101 |
|
|
subependymal glioma
|
DOID_4843 |
|
|
pilomyxoid astrocytoma
|
DOID_4845 |
|
|
EC 3.4.13.19 (membrane dipeptidase) inhibitor
|
CHEBI_76926 |
|
|
EC 3.4.13.* (dipeptidase) inhibitor
|
CHEBI_59499 |
|
|
ganglioneuroma
|
DOID_4817 |
|
|
autonomic nervous system benign neoplasm
|
DOID_0080321 |
|
|
potassium channel opener
|
CHEBI_79085 |
|
|
EC 3.4.24.35 (gelatinase B) inhibitor
|
CHEBI_79088 |
|
|
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
|
CHEBI_79091 |
|
|
EC 1.11.2.* (oxidoreductase with H2O2 as acceptor, incorporating 1 O atom into product) inhibitor
|
CHEBI_79092 |
|
|
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor
|
CHEBI_76811 |
|
|
cerebrotendinous xanthomatosis
|
DOID_4810 |
|
|
EC 2.7.8.* (transferases for other substituted phosphate groups) inhibitor
|
CHEBI_76816 |
|
|
EC 1.11.2.2 (myeloperoxidase) inhibitor
|
CHEBI_79093 |
|
